{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T10:43:25Z","timestamp":1793097805645,"version":"4.5.0"},"reference-count":44,"publisher":"Portland Press Ltd.","issue":"3","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background: The C5 complement inhibitor eculizumab is first-line treatment in atypical hemolytic uremic syndrome (aHUS) going along with a highly increased risk of meningococcal infections. Serogroup B meningococci (MenB) are the most frequently encountered cause for meningococcal infections in Europe. Efficacy of the protein-based MenB-vaccine Bexsero in aHUS has not been determined and testing is only possible in patients off-treatment with eculizumab as a human complement source is required.<\/jats:p>\n                  <jats:p>Methods: Patients with aHUS were vaccinated with two doses of the protein-based MenB-vaccine Bexsero. Serum bactericidal antibody (SBA) titers against factor H binding protein (fHbp) of MenB were determined in 14 patients with aHUS off-treatment with eculizumab.<\/jats:p>\n                  <jats:p>Results: Only 50% of patients showed protective human serum bactericidal antibody (hSBA) titers (\u22651:4) against MenB following two vaccinations. Bactericidal antibody titers were relatively low (\u22641:8) in three of seven patients with protective titers. While 71% of patients were on immunosuppressive treatment for either thrombotic microangiopathy or renal transplantation at either first or second vaccination, all four patients not receiving any immunosuppressive treatment showed protective bactericidal antibody response. Time between second vaccination and titer measurement was not significantly different between patients with protective titers compared with those with non-protective titers, while time between first and second vaccination was significantly longer in patients with protective titers going along with a tendency for reduction in immunosuppressive treatment.<\/jats:p>\n                  <jats:p>Conclusions: Efficacy of vaccination against MenB is insufficient in patients with aHUS. Response to vaccination seems to be hampered by immunosuppression. Therefore, implementation of adequate antibiotic prophylaxis seems pivotal.<\/jats:p>","DOI":"10.1042\/bsr20200177","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T07:30:16Z","timestamp":1583911816000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Low efficacy of vaccination against serogroup B meningococci in patients with atypical hemolytic uremic syndrome"],"prefix":"10.1042","volume":"40","author":[{"given":"Nils","family":"M\u00fclling","sequence":"first","affiliation":[{"name":"Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Rohn","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Vogel","sequence":"additional","affiliation":[{"name":"Institute for Hygiene and Microbiology, National Reference Laboratory for Meningococci and Haemophilus influenzae, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Claus","sequence":"additional","affiliation":[{"name":"Institute for Hygiene and Microbiology, National Reference Laboratory for Meningococci and Haemophilus influenzae, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5115-6799","authenticated-orcid":false,"given":"Benjamin","family":"Wilde","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Eisenberger","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kribben","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Witzke","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3630-4386","authenticated-orcid":false,"given":"Anja","family":"G\u00e4ckler","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2020,3,25]]},"reference":[{"key":"2021111620053928200_B1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12882-015-0195-1","article-title":"The global aHUS registry: methodology and initial patient characteristics","volume":"16","author":"Licht","year":"2015","journal-title":"BMC Nephrol."},{"key":"2021111620053928200_B2","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"2021111620053928200_B3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021111620053928200_B4","doi-asserted-by":"publisher","first-page":"iv131","DOI":"10.1093\/ndt\/gfu235","article-title":"Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab","volume":"29","author":"Verhave","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021111620053928200_B5","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am. J. Transplant."},{"key":"2021111620053928200_B6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predicht recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Am. J. Transplant."},{"key":"2021111620053928200_B7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2215\/CJN.00050505","article-title":"Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background","volume":"1","author":"Bresin","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021111620053928200_B8","doi-asserted-by":"publisher","first-page":"e0188155","DOI":"10.1371\/journal.pone.0188155","article-title":"Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice","volume":"12","author":"de Andrade","year":"2017","journal-title":"PLoS ONE"},{"key":"2021111620053928200_B9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.nefro.2015.07.005","article-title":"An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document","volume":"35","author":"Campistol","year":"2015","journal-title":"Nefrologia"},{"key":"2021111620053928200_B10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/QCO.0000000000000279","article-title":"Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis","volume":"29","author":"Benamu","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"2021111620053928200_B11","doi-asserted-by":"publisher","first-page":"010409","DOI":"10.7189\/jogh.09.010409","article-title":"Meningococcal serogroups and surveillance: a systematic review and survey","volume":"9","author":"Peterson","year":"2019","journal-title":"J. Glob. Health"},{"key":"2021111620053928200_B12","first-page":"333","article-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut","volume":"34","author":"St\u00e4ndige Impfkommission","year":"2017","journal-title":"Epid. Bull."},{"key":"2021111620053928200_B13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0165-5728(90)90146-E","article-title":"Evidence for autoimmune antiobodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis","volume":"29","author":"Nedelec","year":"1990","journal-title":"J. Neuroimmunol."},{"key":"2021111620053928200_B14","doi-asserted-by":"publisher","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111620053928200_B15","doi-asserted-by":"publisher","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111620053928200_B16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"2021111620053928200_B17","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.vaccine.2016.12.032","article-title":"Response to active hepatitis B vaccination and mortality in incident dialysis patients","volume":"35","author":"Zitt","year":"2017","journal-title":"Vaccine"},{"key":"2021111620053928200_B18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/sji.12497","article-title":"Humoral and cellular responses to a single dose of fendrix in renal transplant recipients with non-response to previous hepatitis B vaccination","volume":"85","author":"Lindemann","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"2021111620053928200_B19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/ndt\/gfy225","article-title":"Failure of first menigococcal vaccination in patients with atypical haemolytic uraemic syndrome treated with eculizumab","volume":"35","author":"G\u00e4ckler","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021111620053928200_B20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1182\/blood-2017-05-781450","article-title":"Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults","volume":"130","author":"Konar","year":"2017","journal-title":"Blood"},{"key":"2021111620053928200_B21","article-title":"Bexsero package insert","author":"GlaxoSmithKline GmBH & Co. KG","year":"2019"},{"key":"2021111620053928200_B22","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.vaccine.2010.12.075","article-title":"Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen","volume":"29","author":"Vu","year":"2011","journal-title":"Vaccine"},{"key":"2021111620053928200_B23","first-page":"970","article-title":"Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44\/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine","volume":"12","author":"Borrow","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"2021111620053928200_B24","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/s00103-015-2253-z","article-title":"Background paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease","volume":"58","author":"Hellenbrand","year":"2015","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"2021111620053928200_B25","article-title":"Soliris package insert","author":"Alexion Pharmaceuticals","year":"2018"},{"key":"2021111620053928200_B26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int."},{"key":"2021111620053928200_B27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40620-016-0288-3","article-title":"Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment","volume":"30","author":"Walle","year":"2017","journal-title":"J. Nephrol."},{"key":"2021111620053928200_B28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00103-017-2555-4","article-title":"Impfen bei Immundefizienz: anwendungshinweise zu den von der St\u00e4ndigen Impfkommission empfohlenen Impfungen(I) Grundlagenpapier","volume":"60","author":"Niehues","year":"2017","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"2021111620053928200_B29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/MNH.0b013e328365b3fe","article-title":"Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation","volume":"22","author":"Noris","year":"2013","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"2021111620053928200_B30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1099\/jmm.0.45529-0","article-title":"Neisseria meningitidis: an overview of the carriage state","volume":"53","author":"Yazdankhah","year":"2004","journal-title":"J. Med. Microbiol."},{"key":"2021111620053928200_B31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/tid.12359","article-title":"Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients","volume":"17","author":"Wyplosz","year":"2015","journal-title":"Transpl. Infect. Dis."},{"key":"2021111620053928200_B32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0140-6736(11)61713-3","article-title":"Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b\/3 randomised, observer-blind, placebo-controlled study","volume":"379","author":"Santolaya","year":"2012","journal-title":"Lancet"},{"key":"2021111620053928200_B33","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1016\/j.vaccine.2015.06.103","article-title":"Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: a phase III, randomized, multicentre, lot-to-lot consistency study","volume":"33","author":"Perrett","year":"2015","journal-title":"Vaccine"},{"key":"2021111620053928200_B34","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.vaccine.2018.12.059","article-title":"Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine","volume":"37","author":"Nolan","year":"2019","journal-title":"Vaccine"},{"key":"2021111620053928200_B35","first-page":"E257","article-title":"A new meningococcal B vaccine for adolescents and adults: characteristics and methods of use","volume":"59","author":"Azzari","year":"2018","journal-title":"J. Prev. Med. Hyg."},{"key":"2021111620053928200_B36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/1389201033489900","article-title":"Recombinant hepatitis B vaccination in renal failure patients","volume":"4","author":"Vlassopoulos","year":"2003","journal-title":"Curr. Pharm. Biotechnol."},{"key":"2021111620053928200_B37","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.2215\/CJN.04670511","article-title":"Influenza A\/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study","volume":"6","author":"Broeders","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021111620053928200_B38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ki.2012.106","article-title":"Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination","volume":"82","author":"Mulley","year":"2012","journal-title":"Kidney Int."},{"key":"2021111620053928200_B39","doi-asserted-by":"publisher","first-page":"e12831","DOI":"10.1111\/tid.12831","article-title":"Immunization in end stage renal disease: the perception of waiting list patients","volume":"20","author":"Camargo","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"2021111620053928200_B40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/tid.12473","article-title":"Low rates of vaccination in listed kidney transplant candidates","volume":"18","author":"Lee","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"2021111620053928200_B41","doi-asserted-by":"crossref","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"19","author":"Danziger-Isakov","year":"2019","journal-title":"Clin. Transplant."},{"key":"2021111620053928200_B42","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1469-0691.2007.01767.x","article-title":"Mass antibiotic treatment to stop an outbreak of meningococcal disease: a molecular analysis","volume":"13","author":"Katz","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"2021111620053928200_B43","author":"Alexion Pharmaceuticals","year":"2018"},{"key":"2021111620053928200_B44","doi-asserted-by":"publisher","first-page":"e1506","DOI":"10.1542\/peds.2014-3503","article-title":"Case report: Benefits and challenges of long-term eculizumab in atypical hemolytic uremic syndrome","volume":"135","author":"Cullinan","year":"2015","journal-title":"Pediatrics"}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20200177\/870118\/bsr-2020-0177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20200177\/870118\/bsr-2020-0177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T09:11:19Z","timestamp":1695892279000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/40\/3\/BSR20200177\/222330\/Low-efficacy-of-vaccination-against-serogroup-B"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,27]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20200177","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737537093.793572359","asserted-by":"object"}]},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2020,3]]},"article-number":"BSR20200177"}}